| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-06-12 17:32:05 UTC |
|---|
| Update Date | 2019-07-23 07:14:32 UTC |
|---|
| HMDB ID | HMDB0060530 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-Hydroxytamoxifen |
|---|
| Description | 4-Hydroxytamoxifen, also known as 4-OHT or tamogel, belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. 4-Hydroxytamoxifen is a drug which is used for the potential treatment of menstrual-cycle related mastalgia, fibrocystic breast disease, breast disease, gynecomastia and keloid scarring. 4-Hydroxytamoxifen is a very strong basic compound (based on its pKa). Within humans, 4-hydroxytamoxifen participates in a number of enzymatic reactions. In particular, 4-hydroxytamoxifen can be biosynthesized from tamoxifen through the action of the enzyme cytochrome P450 2D6. In addition, 4-hydroxytamoxifen and uridine diphosphate glucuronic acid can be converted into 4-hydroxytamoxifen-O-glucuronide and uridine 5'-diphosphate; which is mediated by the enzyme UDP-glucuronosyltransferase 1-4. In humans, 4-hydroxytamoxifen is involved in tamoxifen action pathway. 4-Hydroxytamoxifen is a potentially toxic compound. |
|---|
| Structure | CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1 InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25- |
|---|
| Synonyms | | Value | Source |
|---|
| 4-Monohydroxytamoxifen | ChEBI | | 4-OHT | ChEBI | | Tamogel | Kegg | | 4-Hydroxytamoxifen, (Z)-isomer | HMDB | | 4oh-Tamoxifen | HMDB | | Afimoxifene | HMDB | | 4-(1-(4-(2-(Dimethylamino)ethoxy)phenyl)-2-phenylbut-1-enyl)phenol | HMDB | | Tamoxifen metabolite b | HMDB | | 4-OHT hydrotamoxifen | HMDB | | 4-Hydroxy-tamoxifen | HMDB | | 4-Hydroxytamoxifen, (e)-isomer | HMDB | | Para-hydroxytamoxifen | HMDB | | 4'-Hydroxytamoxifen | HMDB | | 4-HYDROXYTAMOXIFEN | ChEBI | | Hydroxytamoxifen | MeSH |
|
|---|
| Chemical Formula | C26H29NO2 |
|---|
| Average Molecular Weight | 387.514 |
|---|
| Monoisotopic Molecular Weight | 387.219829177 |
|---|
| IUPAC Name | 4-[(1Z)-1-{4-[2-(dimethylamino)ethoxy]phenyl}-2-phenylbut-1-en-1-yl]phenol |
|---|
| Traditional Name | 4-hydroxytamoxifen |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC\C(=C(/C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C26H29NO2/c1-4-25(20-8-6-5-7-9-20)26(21-10-14-23(28)15-11-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25- |
|---|
| InChI Key | TXUZVZSFRXZGTL-QPLCGJKRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as stilbenes. These are organic compounds containing a 1,2-diphenylethylene moiety. Stilbenes (C6-C2-C6 ) are derived from the common phenylpropene (C6-C3) skeleton building block. The introduction of one or more hydroxyl groups to a phenyl ring lead to stilbenoids. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Stilbenes |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Stilbenes |
|---|
| Alternative Parents | |
|---|
| Substituents | - Stilbene
- Diphenylmethane
- Phenylpropane
- Phenoxy compound
- Phenol ether
- Alkyl aryl ether
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Monocyclic benzene moiety
- Benzenoid
- Tertiary aliphatic amine
- Tertiary amine
- Ether
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Amine
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.56 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.4663 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.96 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2157.8 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 259.1 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 221.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 198.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 231.3 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 638.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 630.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 428.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1333.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 523.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1473.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 404.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 419.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 246.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 308.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.2 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9134000000-776733ca504d7de5cabd | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen GC-MS (1 TMS) - 70eV, Positive | splash10-0a4i-9104300000-0991f6db19bd6e1d5545 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-Hydroxytamoxifen GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Hydroxytamoxifen LC-ESI-qTof , Positive-QTOF | splash10-0ads-3973000000-bb1382fca99270235a01 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 4-Hydroxytamoxifen , positive-QTOF | splash10-0ads-3973000000-bb1382fca99270235a01 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 10V, Positive-QTOF | splash10-000i-1239000000-84645e53e8de455443fb | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 20V, Positive-QTOF | splash10-00di-9455000000-9cfa2d15949946fc03c7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 40V, Positive-QTOF | splash10-00di-9261000000-b6bb4e0b0330b5c146c1 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 10V, Negative-QTOF | splash10-000i-0009000000-ae47347b1ffe098e2374 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 20V, Negative-QTOF | splash10-014r-1019000000-a006c4264d6b4b3d156f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 40V, Negative-QTOF | splash10-014j-5296000000-6a3ed7fb5ff7614b731a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 10V, Positive-QTOF | splash10-000i-0019000000-4e76d0dc813ddb345686 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 20V, Positive-QTOF | splash10-00dr-8139000000-e48c28363818f855eccb | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 40V, Positive-QTOF | splash10-00di-9100000000-07129b6b7392d8ff3fdc | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 10V, Negative-QTOF | splash10-000i-0009000000-d21bc4977cae5eb4e4dc | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 20V, Negative-QTOF | splash10-000i-0009000000-608b9d736aade52153f2 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-Hydroxytamoxifen 40V, Negative-QTOF | splash10-02tj-0089000000-2a7a41a55ad5dd815901 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|